TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs September 15, 1995
TCL Archive Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement July 25, 2013
TCL Archive Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices September 3, 1993
